RE:RE:RE:AEMD is up 84 cents US todayLets not forget about CTSO, up over 100% from both its 2019 and 2020 (pandemic) lows !
The americans love their innovative medical stories, and blood filtration seems to fit the bill (the 60 minutes tease a few months back helped I guess)
My only complaint is that they don't have a companion diagnostic, so how do they know, for any given patient,which cytokines are elevated (aren't there > 140 different types?)?, what they are removing (aren't there good and bad cytokines?)?, and what is considered a normal level? and might that not differ from patient to patient?
Perhaps one day soon they will begin a FDA Trial that might justify their well deserved, almost 1/2 Billion (CAD $), valuation.
MM
PS maybe the two Companies should collaborate, since I've heard that use of PMX, (although only designed to remove Endotoxins) actually results in reduced levels of IL-6 (the known to be problematic cytokine). Didn't Doc Walker say once that endotoxins are known to be a precursor of cytokines and the eventual cytokine storm? Maybe Spectral could save CTSO from the trouble of conducting a whole Trial over say an 8 to 10 year period. The shareholders might appreciate the cost savings.